Co-Diagnostics (CODX) Tops Q3 EPS by 1c

Co-Diagnostics (NASDAQ: CODX) reported Q3 EPS of ($0.32), $0.01 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $641.14 thousand versus the consensus estimate of $375 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Intel (INTC) PT Lowered to $92 at Mizuho
• Samsara hits $2.1B in ARR with 30% year-over-year growth
• Asana, Inc. (ASAN) Tops Q2 EPS by 1c; offers guidance